SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-001789
Filing Date
2020-01-23
Accepted
2020-01-23 16:38:42
Documents
5
Period of Report
2020-01-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20200121.htm 8-K 34892
2 EX-1.1 xene-ex11_6.htm EX-1.1 394922
3 EX-5.1 xene-ex51_7.htm EX-5.1 11594
4 GRAPHIC gbvbrqp1dv2v000001.jpg GRAPHIC 14552
5 GRAPHIC gbvbrqp1dv2v000002.jpg GRAPHIC 28227
  Complete submission text file 0001564590-20-001789.txt   501701
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 20542593
SIC: 2834 Pharmaceutical Preparations